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Abstract 
 
Obstructive sleep apnea continues to be an area that is underdiagnosed and therefore 
undertreated.  Left untreated, the condition is associated with increased morbidity and mortality 
as it can amplify the risk of multiple health conditions.  Due to the negative impact of obstructive 
sleep apnea it is necessary for healthcare providers to provide timely detection. Primary care 
providers are in a position to identify high-risk individuals and refer them for further follow up 
testing. High-risk identification can be accomplished by integrating validated screening tools into 
patient assessments.  This integrative review provides an overview of current screening tools for 
use in the primary care setting, barriers to screening adoption, and successful practices.  
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Introduction 
Sleep disorders are common in the United States, yet data supports that primary care 
providers (PCP) do not routinely ask about sleep health (Grandner & Malhotra, 2015). 
Obstructive sleep apnea (OSA) is an aspect of sleep health that is grossly under detected 
(American Sleep Apnea Association , 2019). It is a major concern due to the myriad of health 
risks associated with the disorder. A review of current literature is timely to identify strategies 
that can bridge the gap between known under detection and appropriate treatment.  
Background 
Obstructive Sleep Apnea 
Obstructive sleep apnea is a disorder defined by pauses in breathing patterns secondary to 
muscle relaxation, and soft tissue being able to block portions of the upper airway (Harvard 
Medical School, 2011). The collapse of tissue in the pharynx slows or even stops inspiration and 
expiration. A drop in the oxygen level in the blood signals the brain to facilitate a brief 
interruption to the sleep cycle in order to resume breathing (American Lung Association, 2019; 
Mayo Clinic, 2019). Apnea can happen frequently during sleeping without an individual being 
aware (American Lung Association, 2019).  
OSA is different from central sleep apnea, as the pharynx is blocked due to a relaxation 
of muscles in the pharynx rather than a problem originating from a lack of signaling from the 
brain (NIH, 2018). The main types of sleep apnea consist of OSA, central sleep apnea, and a 
combination of obstructive and central apnea. The most common form of sleep apnea is OSA 
(Mayo Clinic, 2019).  Symptoms associated with OSA include snoring, daytime sleeping, pauses 
in breathing, difficulties with memory and concentration, unusual moodiness or irritably, 
frequently waking up to urinate at night, morning headaches, and dry mouth (American Lung 
 
 
Association, 2019). There are several identified risk factors associated with OSA. Some of these 
are preventable and include lifestyle habits and environment, whereas other risk factors based on 
age, family history, genetics, race, and sex are non-preventable (NIH, 2018).   
Obesity is one of the biggest risk factors for OSA, with more than 50% of the diagnoses 
being linked to overweight individuals. This is attributed to an increased tissue deposit around 
the neck. Ethnic groups such as African Americans, Hispanics, and Native Americans are 
disproportionally impacted by the disease, which is likely due to the proportion of obesity in 
these populations (Dudley & Patel, 2016). Age is another one of the major risk factors. While 
sleep apnea can occur at any age, there is a strong correlation with sleep apnea and aging 
individuals. The USPTF and AASM specifically note that those aged 40-70 are considered at 
increased risk for the OSA (Bibbins-Domingo et al., 2017; Semelka et al., 2016). Furthermore, 
individuals under the age of 70 with OSA are noted to be at an increased risk of premature death 
(Franklin & Lindberg, 2015).   
Obstructive Sleep Apnea Questionnaires 
The increasing prevalence of OSA and the underdiagnosis of the condition support the 
need for an effective screening method (American Sleep Apnea Association, 2019; El-Sayed, 
2012).  The Berlin, STOP, STOP-Bang, and Epworth Sleep Study questionnaires are four 
screening tools that are commonly utilized to identify OSA. They have been tested in various 
practice settings. These tools utilize questions based on common signs and symptoms associated 
with OSA (El-Sayed, 2012).  
Berlin Questionnaire 
 The Berlin Questionnaire was developed in 1996 at a primary care conference based in 
Berlin, Germany by a group of primary and respiratory physicians (Tan et al., 2017). This 
 
 
questionnaire was developed specifically for identifying OSA in primary care but does have 
some utility in non-primary care settings (El-Sayed, 2012). It is a questionnaire that stratifies 
individuals into high-or low-risk groups. The questionnaire asks a total of 10 questions along 
with information on patient demographics such as age, gender, height, and weight. The questions 
address common signs and symptoms that can be associated with sleep apnea such as snoring, 
daytime fatigue, obesity, and hypertension (Tan et al., 2017). Scoring for the questionnaire is 
based on three categories with high-risk exhibiting positive findings for two or more of the 
categories (American Sleep Apnea Association, n.d.).  
STOP and STOP-Bang Questionnaire 
 The STOP and STOP-Bang Questionnaires were first developed in 2008 for their utility 
in screening surgical patients (El-Sayed, 2012). The STOP and STOP-Bang utilize four and eight 
dichotomous questions respectively and can be completed quickly. While developed for the pre-
surgical community they have also be utilized and validated in several other patient populations 
(Chung et al., 2016). The STOP-Bang utilizes questions from (STOP) snoring, tiredness, 
observed apnea, and high blood pressure along with demographic information. The Bang portion 
of the questionnaire includes information regarding body mass index (BMI), age, neck 
circumference, and gender (Chung et al., 2016).   
Epworth 
The Epworth Sleepiness Scale was developed in 1991 and is another common tool that 
can be utilized to screen for sleep apnea since sleepiness is one of the common symptoms 
associated with OSA. However, this tool only provides a subjective assessment of daytime 
sleepiness and does not include some of the other symptoms that can be associated with OSA. It 
 
 
is important to note that not all patients with OSA present with daytime sleepiness (Omobomi & 
Quan, 2018). 
Problem Statement 
OSA is a growing concern within the United States as there are an estimated 22 million 
Americans that suffer from the condition. The national average for the condition is postulated to 
range between 2-10% of the adult population (Miles et al., 2017). Additionally, data supports 
that 80% of moderate to severe obstructive sleep apnea remains undiagnosed (American Sleep 
Apnea Association , 2019).  There is a strong correlation of OSA among obese populations, and 
in western society the prevalence of OSA is speculated to increase (Garvey et al., 2015).    
It is important to note that the general public does not routinely recognize symptoms or 
associated severity with OSA (Frost & Sullivan, 2016).  Another identified barrier is that primary 
care providers do not routinely ask patients questions related to sleep quality or duration (Frost & 
Sullivan, 2016). Providers may not investigate an early OSA diagnosis if the patient does not 
present with a complaint of fatigue or classic high body mass index (BMI). This can be further 
complicated since fatigue can also be credited to existing comorbidities. However, evidence 
supports that lack of fatigue does not rule out sleep breathing disorders and as much as 50% of 
individuals with OSA are not obese (Osman et al., 2018). 
Economic 
The health risks associated with untreated sleep apnea can also have noteworthy 
economic consequences as the AASM estimates that undiagnosed OSA cost the United States 
$149.6 billion dollars in 2015 alone (Frost & Sullivan, 2016). The economic strain of the chronic 
condition impacts not only the nation, but individuals as well. Direct costs of obstructive sleep 
apnea are associated with co-morbidities, workplace injuries, and car accidents. Meanwhile, 
 
 
indirect costs associated with OSA may include reduced productivity, quality of life, and strain 
on relationships (Frost & Sullivan, 2016).  
Co-Morbidities & Complications 
Sleep apnea is a significant problem since untreated sleep apnea can increase risks 
associated with asthma, some cancers, hypertension, arrhythmias, heart disease, chronic kidney 
disease, cognitive and behavioral disorders, eye disorders, stroke, diabetes, pregnancy 
complications, and premature death (Knauert et al., 2015; NIH, 2018).   
Asthma  
It is noted that patients with asthma have a greater chance of OSA when compared to the 
general population, with OSA potentially worsening asthma-related outcomes. Evidence 
supports that asthma patients with OSA have a higher association with poor asthma control, 
increased nocturnal symptoms, and recurrent exacerbations. While there is a link between asthma 
and OSA the exact mechanics behind the process remain hypothetical, but OSA has been 
associated with airway remodeling due to inflammation. Patients with OSA and asthma that are 
treated with a CPAP seem to have improvement of symptoms as evidenced by peak flow 
readings and reported quality of life (Dixit, 2018).  
Cancer 
 Obstructive sleep apnea has also been associated with an increased risk of cancer 
mortality. A Wisconsin sleep cohort study published by Nieto et al. (2012) demonstrated an 
increase in mortality among cancer patients with severe sleep breathing disorders compared to 
those without. The association between cancer mortality and sleep breathing disturbances 
remained high even after accounting for variables such as “age, sex, smoking, BMI, physical 
activity, diabetes, weight circumference, and sleep duration” (National Sleep Foundation, 2019; 
 
 
Nieto et al., 2012, p. 192). While there is a correlation, there is not a clear understanding of 
whether OSA contributes to the formation of cancer or mainly facilitates its growth.  However, 
animal studies demonstrate that intermittent hypoxia promotes angiogenesis and tumor growth 
(National Sleep Foundation, 2019). 
Hypertension 
Multiple studies and papers have been dedicated to demonstrating the link of obstructive 
sleep apnea with resistant hypertension. Resistant hypertension is characterized as elevated blood 
pressure that elicits a poor response to treatment requiring multiple medications (Yaxley & 
Thambar, 2015). There are several proposed theories regarding the pathology behind severe OSA 
and resistant hypertension. Severe OSA has correlated with poor blood pressure control and 
increased cardiovascular risk.  CPAP therapy may provide benefits by reducing blood pressure 
and overall cardiovascular disease risk (Harding, 2014).   
Arrhythmias 
 Several arrhythmias have been associated with obstructive sleep apnea. Atrial fibrillation 
is a common arrhythmia encountered in patients with OSA. The exact pathophysiology behind 
the development of arrhythmias in individuals with OSA remains unclear, but there are a few 
hypotheses that have been suggested. A hypothesis is that reduced blood oxygen saturation and 
increased carbon dioxide levels cause complications in both the chemoreflex and baroreflex 
functions (Patel et al., 2019). This could lead to an activation of the sympathetic system and 
electrical remodeling within the heart. Another proposed hypothesis is that hypertension that 
often coincided with OSA, is linked to the development of atrial fibrillation. Evidence supports 
that hypertension can cause atrial remodeling. Continuous positive airway pressure (CPAP) has 
 
 
shown to be effective in the treatment of OSA and has the benefit of reducing the incidence of 
arrhythmia in OSA patients (Patel et al., 2019).  
Chronic Kidney Disease 
 Obstructive sleep apnea has a causal link with chronic kidney disease (CKD) due to the 
association with chronic hypertension. OSA, through the cycling of sleep fragmentation and 
arousals, contributes to the progression by increasing sympathetic nerve discharge, renin-
angiotensin-aldosterone system (RAAS) activation and increased vascular resistance. Studies on 
OSA have been associated with glomerular hyperfiltration and glomerular sclerosis (Adeseun & 
Rosas, 2010). Data suggests that there is a bidirectional relationship between OSA and CKD 
with OSA contributing to the progression of CKD and CKD worsening the risk associated with 
OSA (Abuyassin et al., 2015). 
Memory and Behavioral Disorders 
Several studies have demonstrated that cognitive impairment is a complication associated 
with OSA. Deficits in executive functioning, memory, and attention are one of the negative 
consequences of the disorder. Executive function includes the ability to reason, perform tasks, 
plan, and engage in problem solving.  Obstructive sleep apnea is not exclusive to the adult 
population and can be seen all ages. Furthermore, cognitive disfunction linked with the OSA has 
been observed in children as well as adults (Krysta et al., 2017). The exact prevalence of 
cognitive dysfunction associated with OSA is unknown as there is large variation within studies. 
Variations such as heterogenicity of the sample, premorbid IQ, education level of the subjects, 
oxygen levels, selection of a comparison group, and even continuity in memory tasks are 
important to note. Combination studies of neurophysiological and neuroimaging have helped to 
further support the link of cognitive decline in patients with OSA (Krysta et al., 2017).  
 
 
Eye Disorders 
Obstructive sleep apnea is associated with several ophthalmic conditions. Floppy eye 
syndrome, glaucoma, and nonarterial anterior ischemic optic neuropathy are some of the 
conditions that appear to have a link with OSA. Due to the increased risk of eye disorders in 
patients with OSA it is important that physicians are aware and refer patients to obtain 
ophthalmic evaluation and any necessary treatment (Skorin & Knutson, 2016).   
Stroke 
Obstructive sleep apnea is an independent risk factor for stroke patients. Left untreated, 
OSA in stroke patients could lead to a recurrent stroke. It is also to be noted that OSA has a 
bidirectional relationship with severity of the stroke manifestations and the degree of recovery 
after a stroke. CPAP therapy has proven beneficial in improving cognitive and overall function 
among stroke patients with OSA (Jehan et al., 2018).  
Diabetes 
The association of OSA and type II diabetes are suggested to be independent of age-
related changes or obesity (Muraki et al., 2018). Furthermore, OSA is noted as a co-morbidity of 
diabetes due to the increased prevalence in the diabetic population and nearly half of type II 
diabetics suffering with OSA.  The association of decreased insulin sensitivity and OSA has been 
demonstrated through animal studies with intermittent hypoxia. It is believed that the 
sympathetic pathway is activated by the intermittent hypoxia resulting in oxidative stress and 
systemic inflammation that subsequently cause changes in hormonal balance (Muraki et al., 
2018). 
 
 
Pregnancy Complications 
While sleep apnea is relatively low among women of reproductive age. It is important to 
note that pregnancy does increase risk of sleep disordered breathing (SDB). While the exact 
cause is not well understood “the physiological hormonal, mechanical, and cardiovascular 
changes of pregnancy may place women at risk of developing SDB or exacerbate existing sleep 
disorders” (Izci, 2015, p. 270). Higher levels of estrogen, progesterone, and other hormones may 
play a significant role in the anatomical narrowing and resistance due to capillary engorgement, 
hypertension, and edema (Izci, 2015).  
Premature Death 
A large sleep study that was conducted for over 18 years indicated that patients with 
severe sleep apnea have a mortality rate that is approximately three times greater than individuals 
without apnea (UWHealth, 2016; Young et al., 2008).  This study consisted of a randomized 
sample of men and women (n= 1,522) within the community between the ages of 30 and 60 at 
the start of the study. Findings of the study indicated a high all-cause mortality risk with severe 
sleep breathing disorders even when adjusted for age, sex, and BMI. This study highlights the 
importance of clinical recognition and treatment of SBD (Young et al., 2008). Furthermore, the 
Wisconsin Sleep Cohort supports that continuous positive air pressure therapy (CPAP) does 
reduce overall mortality (AASM, 2008).  
Purpose of the Project 
The scholarly project's purpose was to seek improvement in healthcare screening 
practices for OSA in primary care settings by the identification of best screening tools for the 
PCP, detection of barriers, and strategies to increase OSA screening. These goals were developed 
as there continues to be gap between the known under detection and lack of routine questions 
 
 
regarding sleep health in primary care (Grandner & Malhotra, 2015). This project initiative 
correlated with the American Academy of Sleep Medicine’s suggestion to screen individuals that 
are considered high-risk based on risk factors (AASM, 2017).  
Clinical Question 
This review of the literature sought to answer clinical questions to improve detection and 
standardization of OSA screening in primary care. The clinical questions aimed to promote 
timely identification of sleep apnea risk for patients that could be used to determine a need for 
further follow-up testing. Additionally, the review considered best methods to integrate sleep 
apnea screening into primary care to promote sustainability.  Three clinical questions guided the 
integrative review of the literature and provided a broad scope of the current facilitators and 
barriers to OSA screening by primary care providers.  
Project Goals 
1.) What valid and reliable OSA questionnaires, for the adult population, have the best 
utility in the primary care setting? 
2.) What are perceived barriers among health professionals in utilizing OSA screening 
questionnaires in primary care?  
3.) What practices have been successful in increasing OSA screenings for high risk 
patients? 
Methods 
Protocol and Framework  
Integrative reviews are described as a review of the available research and should uphold 
a standard in methodology (Whittemore & Knafl, 2005). “The integrative review method can 
incorporate diverse methodologies in order to capture the context, processes, and subjective 
 
 
elements of the topic” (Whittemore & Knafl, 2005, p. 552). Robust integrative reviews have the 
potential to advise further research, policy, and practice initiatives. While this method can 
provide a holistic view on an issue the combination of different study types can make this 
process a challenge (Whittemore & Knafl, 2005). Utilization of a framework in the integrative 
review process facilitates systematic practices and sets a standard for academic excellence. The 
OSA integrative review utilizes the Preferred Reporting Items for Systematic Review and Meta-
Analyses (PRISMA) framework as a means to safeguard quality.  
The PRISMA framework was developed during 1996 in response to an identified need 
for improved the reporting quality of meta-analyses (Moher et al., 2009). This framework 
utilized a 27-point checklist along with a four-phase flow diagram (Moher et al., 2009). The 
PRISMA checklist was utilized to outline the paper with seven main headings and multiple sub-
headings. The four-phase diagram was also utilized to map the systematic approach of collecting 
scholarly articles for the integrative review. The PRISMA flow diagram methodology is 
embraced as it guides the reviewer in carefully formulating a question, meticulously identifying 
articles, screening, and inclusion of literature in the integrative review (Moher et al., 2009; 
Whittemore & Knafl, 2005). The integrative review method with PRISMA is further 
characterized by an analysis of studies included with or without statistical scrutiny (Moher et al., 
2009). Whittemore and Knafl (2005) supplemented the PRISMA checklist and flow diagram by 
offering further suggestions in the data analysis stage through data reduction, data display, data 
comparison, conclusions and verification.  
Eligibility Criteria 
 Inclusion criteria for the integrative review, on the topic of obstructive sleep apnea, 
included articles that were published in or after 2016 and in the English language. Clinical 
 
 
questions helped to narrow the search further to those looking at questionnaire use in the primary 
care setting for the adult population. References were not limited to the United States and 
included studies conducted around the world. Exclusion criteria for journal articles and reports 
comprised those published before 2016 as well as those that were published in a foreign 
language. References with questionnaire use in the hospital, specialty practices, or with children 
were also excluded from the search.  
Information Sources 
 Liberty University’s online library was utilized to search clinical databases for scholarly 
and relevant sources. Both ProQuest Medline and ProQuest: Nursing and Allied Health 
Databases were utilized in the integrative review as these databases contain a wealth of scholarly 
sources focused in health and medicine. Resources within these databases were carefully 
reviewed for literature that was peer reviewed. DNP dissertations and scholarly projects were 
also included in the review to increase evaluation on the topic of OSA screening.  The PRISMA 
flow diagram facilitated a systematic approach to obtaining and documenting sources based on 
the inclusion and exclusion criteria. These databases and the approach guided by PRISMA 
provided a means to review current literature for questionnaire utility in the primary care setting, 
perceived provider barriers, and strategies that have proved beneficial in increasing OSA 
screening.  
Search 
 Since an integrative review is not meant to simply be a list of the current and available 
literature, there is a process that should be utilized to standardize how literature is obtained and 
reviewed. An expansive literature search was conducted utilizing ProQuest Medline and 
ProQuest Nursing and Allied Health. Databases, such as the ones reviewed, are gateways to 
 
 
rendering a body of evidence (Melnyk & Fineout-Overholt, 2019). A keyword search was 
conducted in both of these large databases. Key words that were used in the search included 
sleep apnea, obstructive sleep apnea, primary care, questionnaire, and adult. Literature that met 
inclusion criteria was saved and then appraised based on Melnyk’s hierarchy of evidence 
(Melnyk & Fineout-Overholt, 2011).  
 Of the 15 total articles systematically obtained, 13 were primary sources with the 
remaining coming from secondary sources. Melnyk’s hierarch of evidence assessed the strength 
of the articles included for merit in directing clinical practice. A range of evidence was identified 
for the articles found that met both the inclusion and exclusion criteria. Two articles included in 
the integrative review consisted of systematic reviews (level II) which are defined as including at 
least one randomized control trial. One study included a quasi-experimental approach classified 
as a level III in terms of evidence. Ten studies included in the review consisted of case control or 
cohort studies and ranked as a level IV in evidence quality. A qualitative study was also included 
and provided level VI evidence (University of Michigan, 2020).  
Study Selection 
 The integrative review (IR) of literature was conducted to identify current best practices 
for OSA screening in the primary care setting. Liberty University Institutional Review Board 
(IRB) approval for the IR scholarly project was requested and obtained in accordance with 
university standards. Following the PRISMA flow diagram with inclusion and exclusion criteria 
provided 15 applicable journal articles. The 15 articles were extracted from the total 893 articles 
after completing a key word search for articles published after 2015 using the two ProQuest 
databases.  
 
 
Data Collection Process 
 A search for available literature was done by utilizing Liberty’s online library. Medical 
databases were chosen and included both ProQuest Medline and ProQuest: Nursing and Allied 
Health to discover relevant articles on the topic of OSA screening tools in primary care. There is 
a significant amount of literature available for OSA and screening tools. However, this particular 
search was limited to studies with a focus on the primary care role in the discovery and treatment 
of the OSA disorder utilizing screening tools. Studies were also limited to those that were 
published within the last five years to provide current evidence.  
Data Items 
 Selection of available articles found through the two ProQuest databases was a rigorous 
process done to narrow down to the specific data items that addressed the clinical questions. 
Reduction of the vast number of articles, available through the key word search, was done 
systematically and the PRISMA model served as a guide for inclusion of relevant articles. 
Eligible full text articles were read, and data was sifted through based on the subject and setting 
of the study. Organization of the data items was achieved through the PRISMA flow diagram 
and synthesis chart of eligible articles.  
Risk for Bias in Individual Studies 
 Integrative and systematic reviews require consistency in the approach of identifying, 
reviewing, and synthesizing articles to provide current evidence on clinical enquiries. Following 
the PRISMA checklist and flow diagram helped to reduce bias as the writer documented the 
approach and included all relevant literature on the topic of interest rather than just selecting 
articles that supported a particular approach. The organized review of literature can help 
 
 
healthcare leaders recognize the broad scope on an issue and make well informed decisions that 
impact services provided (Liberati et al., 2009).  
Summary Measures 
 The purpose of the integrative review was to answer the clinical questions of OSA 
questionnaire utilization in the primary care setting. Finding tools with the best utility, 
identification of barriers, and recognizing facilitators was accomplished and charted in a 
literature results matrix. This matrix provides an overview of the applicable articles found by 
including the focus of the article, level of evidence, background, practice implications and 
recommendations.  
Synthesis of Results 
 Literature notes a continued lack of OSA diagnosis and treatment which prompted a 
review of current literature for primary care strategies in addressing the continued under 
identification and treatment. Several OSA screening tools were identified during the literature 
review to aid providers in discovery of high-risk signs and symptoms among patients. A few 
barriers to screening tool adoption along with recommendations for practice were included to 
improve the process of screening tool utilization in clinical practice.  
Results 
Study Selection 
 The review of literature rendered a total of 893 articles using two ProQuest databases 
with keyword search and limiting articles to those published after 2015. The PRISMA flow 
diagram was utilized to navigate the selection of applicable articles. The diagram provided a top 
down approach for mapping the inclusion of articles. Identification, screening, eligibility, and 
inclusion represented the steps to systematically reviewing scholarly sources. The flow chart first 
 
 
displayed the total number of articles identified with each database and include ProQuest 
Medline (641) and ProQuest: Nursing and Allied Health (252).  After duplicates from the two 
databases were removed a total of 461 articles were available for screening. Of these articles, 
420 were excluded for not meeting both the inclusion and exclusion criteria. The remining 55 
articles were reviewed for eligibility based on relevance to the clinical questions. Based on the 
clinical question, one qualitative and 14 quantitative articles were included in the integrative 
review (See Appendix A).  
Study Characteristics  
A results matrix table was utilized to summarize the findings and appraise the evidence. 
Including both qualitative and quantitative articles is one of the benefits of conducting an 
integrative review.  The methods of conducting an integrative review allowed for articles with 
mixed methodologies such as experimental and non-experimental research that provided a robust 
examination of available evidence (Whittemore & Knafl, 2005). Three clinical questions guided 
the search for relevant articles to address the validity of screening tools, perceived barriers, or 
successful practices in increasing screening practices within the primary care. No identifiable 
bias was noted within or across the articles included in the review.   
Synthesis of Results 
 Whittemore and Knafl (2005) detailed the data analysis process for an integrative review 
and noted that there are four distinct parts to a detailed synthesis. The analysis advances through 
data reduction, data display, data comparison, conclusions drawn and verification. This 
systematic process helps to mitigate formulating premature conclusions (Whittemore & Knafl, 
2005). 
 
 
Data Reduction  
The data reduction phase describes the classification and sub-categorization of articles. 
This process can account for articles based on the chronology, setting, sample characteristics, or 
other predetermined conceptual classification (Whittemore & Knafl, 2005). Data was reduced 
using inclusion and exclusion criteria and further dwindled down based on the topics that 
answered the preformulated clinical questions.  
Data Display  
 The next step to data analysis included displaying the themes from the multiple sources. 
Whittemore and Knafl (2005) stated that the data may be displayed using various forms such as 
matrices, graphs, charts, or networks to provide a clear comparison across sources. Displaying 
data in one or multiple forms helps to improve visualization for further interpretation. The 
literature matrix table was developed to sort data by providing the level of evidence, background, 
and conclusions for each article.  
Data Comparison 
 Data comparison was then completed after finalizing the literature matrix table. Articles 
that corresponded with the clinical questions were sorted and reviewed. The matrix table proved 
beneficial in the process of comparing and contrasting the themes of reliable OSA 
questionnaires, perceived barriers, and successful practices.  
Conclusions Drawn and Verification 
 After a careful review of the available articles, conclusions were drawn and identified in 
the summary of evidence. The review of available screening tools, barriers, and successful 
practices provided a comprehensive depiction of the evidence. Generalities emerged from the 
 
 
available articles to provide recommendations for integration into clinical practice through policy 
changes or suggestions for further study.  
Additional Analysis  
Valid and Reliable OSA Questionnaires 
 The review of literature revealed a total of seven different screening tools that have been 
tested in the primary care setting. The sensitivity and specificity data of the screening tools 
depended largely upon the population screened as well as the data apnea-hypopnea index (AHI) 
set point. The AHI notes the severity of sleep apnea and results can be classified as normal (0-5) 
sleep, mild apnea (5-15), moderate apnea (15-30), or severe apnea (>30) (Miller & Berger, 
2016). While some of the studies offered sensitivity and specificity data on all severity cutoffs 
others offered sensitivity and specificity data only on a single AHI cutoff such as moderate apnea 
(Miller & Berger, 2016). The STOP-Bang was by far the most utilized tool within the articles 
reviewed. The Berlin Questionnaire and Epworth Sleepiness Scale both tied for the second most 
common tools used within the available literature. Literature supports that the Berlin and STOP-
Bang currently offer the best measures for the presence of moderate and severe apnea (Miller & 
Berger, 2016). Use of the Epworth as an initial screening tool for OSA is cautioned due to 
inconsistency with both sensitivity and specificity (Aurora & Quan, 2016; Miller & Berger, 
2016).  
STOP and STOP-Bang.  The STOP-Bang was identified in nine of the articles included 
in the review. Some provided data on the utility of this screening tool in the primary care setting, 
whereas other articles looked at the process of implementing the questionnaire in the clinical 
practice. The STOP questionnaire is a precursor to the STOP-Bang and was only reviewed in one 
of the articles (Miller & Berger, 2016). While the STOP and STOP-Bang screening tools were 
 
 
initially designed for the pre-surgical population, the STOP-Bang was readily used in the articles 
reviewing the primary care setting due to the high sensitivity data and ease of use (Miller & 
Berger, 2016).  
A study that compared the STOP-Bang against the Berlin Questionnaire within the 
diabetic population found the STOP-Bang had the highest sensitivity (87.2) for mild apnea but 
was nonspecific to OSA. The STOP-Bang along with the Berlin has even better sensitivity with 
moderate and severe apnea. Sensitivity improved but was still poor with moderate and severe 
sleep apnea for both the STOP-Bang and Berlin (Edmonds et al., 2019). Another study reviewed 
the utility of the STOP-Bang with patients suspect to have a sleep disorder and referred by their 
primary care providers for a sleep study. The STOP-Bang used with individuals suspected to 
have a sleep disorder provided a 98.62% sensitivity and 33.33% specificity (Rebelo-Marques et 
al., 2018).  
Berlin. The Berlin Questionnaire was implemented in four of the journal articles. This 
questionnaire consistently had lower sensitivity than the STOP-Bang but offered an 
improvement in specificity (Edmonds et al., 2019; Senaratna, 2019). As previously noted, a 
literature review looking at Epworth, Berlin, and STOP-Bang screening questionnaires 
highlighted that the Berlin and STOP-Bang currently offer the best questionnaire for OSA in the 
primary care setting (Miller & Berger, 2016).    
Epworth. Studies recommended against the use of the Epworth Sleepiness Scale (ESS) 
as an initial screening of OSA due to lack of consistency with sensitivity and specificity data 
(Aurora & Quan, 2016; Grover et al., 2016; Miller & Berger, 2016). Another study reviewed the 
ESS in conjunction with the Berlin, STOP-Bang, and OSA-50 to determine how it would impact 
predictive values. The ESS helped to raise the specificity from 21%-59% to 92-95% when used 
 
 
with all three tools but also lowered the sensitivity from 65%-86% to 36%-51% (Senaratna, 
2019). 
Phillips. Data on the Phillips questionnaire was limited to a single article that reviewed 
its function when used with overnight oximetry (Fabius et al., 2019). The study was able to 
optimize cutoffs for the oximetry data index (ODI) and questionnaire based on results from 
patients referred for sleep studies. A sensitivity of 99% and specificity of 65% was achieved 
utilizing a two-step screening method using both the Phillips questionnaire and oximetry. Using 
the two-step method improved sensitivity results beyond using oximetry data alone (Fabius et al., 
2019).  
OSA 50. The OSA 50 screening tool was included in an article that cross analyzed the 
sensitivity and specificity with the STOP-Bang & Berlin alone and in combination with the 
Epworth Sleepiness Scale for moderate OSA. The OSA 50 provided moderate sensitivity (86%) 
but low specificity (21%).  Specificity (92%) for this tool improved when used with the ESS but 
sensitivity (51%) data was impacted. The OSA 50, when compared against the other tools 
provided the highest sensitivity but the lowest specificity (Senaratna, 2019).  
SACS tool. The SACS tool was used in only one of the articles reviewed. This tool was 
provided to a convenient sample of patients within the primary care setting with clinical 
suspicion of sleep apnea.  It is important to note that the study classified OSA as an AHI>10. 
The SACS provided a sensitivity (44%) and specificity (89%) for moderate sleep apnea 
(AHI>15). (Grover et al., 2016).  
Perceived Barriers 
 Reviewing perceived screening barriers is important since there is a lack of utilization of 
OSA questionnaires within the primary care setting (Bakhai et al., 2017; Devaraj, 2020; Khan et 
 
 
al., 2019). Several articles addressed some of the perceived barriers to OSA screening in the 
primary care setting. Five main themes emerged with the review of included articles. Studies 
determined that inconsistency with practice guidelines, lack of awareness regarding available 
screening tools, current screening test predictive values, time constraints, and electronic medical 
record (EMR) limitations (Aurora & Quan, 2016; Bakhai et al., 2017; Khan et al., 2019; 
Kleisiaris et al., 2016; Ononye et al., 2019). 
Inconsistency with Guidelines. Screening guidelines vary across professional 
organizations. The United States Preventative Services Task Force (USPSTF) position does not 
recommend OSA screening in the general population whereas the American College of 
Physicians’ guideline recommends screening individuals with symptoms such as unexplained 
fatigue. The American Academy of Sleep Medicine recommends screening all high-risk 
individuals such as those with atrial fibrillation (AF), obesity, hypertension, heart failure, stroke, 
diabetes, and pulmonary hypertension (Khan et al., 2019). The lack of consistency across 
guidelines makes it challenging to know what organizational recommendations to follow.  
Time Constraints & Low Reimbursement Rates. Limitations on available time to 
conduct screening questionnaires in the office was another barrier noted (Bakhai et al., 2017). A 
quality improvement study performed a root cause study to evaluate patient, physician, and 
material barriers to adoption of OSA screening. The extra time needed to complete the screening 
forms was one of the physician barriers listed (Bakhai et al., 2017). Furthermore, low 
reimbursement rates were an identified barrier that made screening for OSA less of a priority in 
busy practice settings (Addogoh, 2018).  
 
 
Lack of Awareness. A review of perceived barriers was done in a quality improvement 
study and noted that one of the challenges was a lack of awareness of available screening tools as 
well as education on appropriate sleep screening (Khan et al., 2019). This finding was supported 
by several other articles (Bakhai et al., 2017; Miller & Berger, 2016). Furthermore, primary care 
providers need to be educated on what high-risk groups and symptoms require further follow up 
(Ononye et al., 2019; Kleisiaris et al., 2016).  
Screening Test Predictive Values. Lack of assessment may also be linked to screening 
tests failing to provide a combination of high sensitivity and high specificity (Miller & Berger, 
2016). Most OSA screening tools provide high sensitivity but low-to-moderate specificity. 
However, multiple articles conclude that there needs to be routine screening for OSA in the 
primary care setting (Aurora & Quan, 2016; Kleisiaris et al., 2016; Miller & Berger, 2016; 
Showalter & OʼKeefe, 2019).  
Electronic Medical Record Limitations. An additional shortfall to OSA screening 
identified in the literature search pointed to limits within the electronic medical records (Bakhai 
et al., 2017). For practices that have OSA screening tools available in the EMR it is important to 
note the extra steps of manual calculation and documentation added to a clinical workflow 
(Bakhai et al., 2017). The absence of an automated algorithm and clinical decision support was 
recognized as the greatest barrier to a quality improvement process aimed at increasing detection 
and referral of high risk OSA patients (Bakhai et al., 2017). 
Successful Practices 
 Review of successful practices to increasing OSA screening for high risk patients was 
another aspect of the literature review.  Three main themes emerged in regard to helpful 
 
 
interventions for primary care practices. These themes include staff education, development of 
an OSA screening protocol, and EMR improvements.   
Staff Education. As noted earlier, lack of education or awareness on available screening 
tools was one of the perceived barriers to OSA screening. Several studies noted that primary care 
providers would likely benefit from further training on detection of OSA and impact of untreated 
OSA (Devaraj, 2020; Khan et al., 2019; Miller & Berger, 2016). However, training should not be 
limited to practitioners and should also include other key clinical personnel such as medical 
office assistances, nurses, and clinic administrators. Education on OSA screening includes how 
to administer as well as the value and potential benefit of routine OSA screening (Aurora & 
Quan, 2016). Implementing an OSA screening training program has proven successful in 
improving screening and referral rates for high risk patients within the primary care setting 
(Addogoh, 2018).  
OSA Screening Protocol. Another identified strategy for improving screening within the 
primary care is to provide a screening protocol within the practice setting (Addogoh, 2018; 
Ononye et al., 2019; Miller & Berger, 2016; Showalter & OʼKeefe, 2019).  Several of the 
screening protocols proved successful in identifying OSA high-risk patients that had not been 
previously identified.  Despite the recommendation to create a screening protocol for OSA there 
were inconsistencies with what groups were screened and with what screening tool. In line with a 
screening protocol was a recommendation to provide the screening tool to high-risk patients 
prior to clinic visits (Aurora & Quan, 2016).  Implementing a protocol that allows for completion 
of the screening tool prior to the clinical visit can help improve workflow and mitigate time 
restraints (Aurora & Quan, 2016).  
 
 
Electronic Medical Record. The third main theme for improving success with OSA 
detection and screening suggests the use of an electronic medical record. Several studies were 
limited in the extent of being able to utilize the EMR, but suggested built-in alerts and reminders 
through clinical support tools, integration of the screening tool in the EMR, and hard stops to 
complete screening tools for at risk patients (Addogoh, 2018; Aurora & Quan, 2016; Grover et 
al., 2016; Johnson, 2019; Miller & Berger, 2016; Senaratna, 2019; Showalter & OʼKeefe, 2019). 
Integrating the screening tool in the EMR can help to streamline the process by reducing the time 
healthcare providers are spending to manually entering OSA screening questionnaires (Bakhai et 
al., 2017). However, use of clinical support tools and alerts should be further explored (Grover et 
al., 2016). 
Discussion  
Summary of Evidence 
 The articles reviewed provided substantial support for adoption and integration of OSA 
screening tools in the primary care setting. Primary care providers are in an important position to 
facilitate early screening (Aurora & Quan, 2016). Despite this, lack of sufficient screening 
continues to be an issue within primary care (Addogoh, 2018; Bakhai et al., 2017; Khan et al., 
2019; Ononye et al., 2019). While the benefit of implementing screening is recognized, research 
is still needed regarding the best strategies for timely identification of patients that have 
undiagnosed OSA. Prominent guidelines provide different suggestions regarding screening only 
symptomatic individuals or screening high risk. However, it is important to note that none of the 
screening guidelines recommend widespread screenings for all primary care patients (Khan et al., 
2019.)  
 
 
 In addition to the variation in professional guidelines, there remain barriers that need to 
be overcome in order to improve identification of OSA positive patients. The limitations in the 
study pointed to the need for improved healthcare education on OSA impact and available 
screening tools, enhancement of EMR capability, along with financial reimbursement for time 
spent screening. Furthermore, while the screening tests tend to have high sensitivity, they 
consistently provide low specificity for OSA requiring a thorough work up and follow up testing 
to make a diagnosis.   
Multiple articles noted that use of sleepiness scales, such as the ESS, are not ideal for 
identifying high risk OSA patients due to variability in predicting the presence or absence of 
sleep apnea (Aurora & Quan, 2016). But this tool continues to be used for initial screening 
(Addogoh, 2018; Johnson, 2019). The STOP-Bang was one of the most widely used tools in the 
review of literature. The tool is easy to use with eight dichotomous questions in addition to being 
consistent with the sensitivity and specificity (Miller & Berger, 2016). 
Limitations 
 The integrative review does have some limitations. Limitations noted within the review 
of literature include articles that were not limited to the United States. Additionally, the articles 
included in the review predominately consisted of level IV (case control or cohort) studies and 
look for correlations. While these studies add to the pool of evidence they are not as strong as 
randomized control trials  (University of Michigan, 2020). Barriers to OSA screening identified 
in the review of literature were predominately noted by interviewing healthcare providers and 
could impact the strength of the findings (Bakhai et al., 2017). Some of the successful practices 
were tested in the review of literature but there were limitations in testing the impact of 
 
 
modifying the capability of the electronic medical record. Most studies noted that improvements 
within the EMR would likely help but this was not studied in the articles reviewed.  
Conclusions 
 Literature supported the need for increased detection of obstructive sleep apnea. Primary 
care clinics are an opportune setting to identify high risk OSA individuals. The integrative 
review utilized mixed method articles to identify current screening tools, barriers, as well as 
facilitators to increasing OSA screening in the primary care. The screening tools were reviewed 
for their utility in the primary care setting and revealed most screening tools to have a high 
sensitivity but low specificity. The perceived barriers and recommended facilitators to improve 
OSA screening provide suggestions for practice changes and further research. OSA will remain 
under detected and undertreated unless action is taken to pursue best methods for detection, 
streamline the screening process, and implement strategies for continued improvement. 
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Tables 
Table 1 
 
Inclusion and Exclusion Criteria 
 
Inclusion Criteria Exclusion Criteria 
Publications from 2016-2020 Publications during or prior 
 to 2015 
Adult patient population (>18 yrs.) Pediatric patient population (<18 yrs.)   
Peer-reviewed, gray literature (i.e. 
unpublished articles, dissertations, 
frameworks, policy documents, etc.) 
Non-research articles (i.e. 
commentaries, editorials, briefings, 
fact sheets) 
Primary Care Hospital or Specialty Practice  
Full-text articles Abstract only articles 
English language Publications written in a foreign 
language 
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Table 2 
 
Results Matrix Obstructive Sleep Apnea Screening in Primary Care 
 
Focus of 
Article, 
Author/year 
Level of 
Evidence/Source 
OSA/ Background Conclusions/ Practice Implications/ Recommendations 
Comparing neck 
grasp and 
circumference to 
STOP-Bang and 
Berlin 
questionnaires in 
the primary care 
population 
among type 2 
diabetics.  
(Edmonds, 
Gunasekaran, & 
Edmonds, 2019). 
IV/Primary § Convenient sample 
of type 2 diabetics 
from an internal 
medicine clinic for 
routine visits 
between 2015-
2016.  
§ 86 participants 
were screened with 
43 meeting 
inclusion criteria 
(Type 2 diabetes 
and no prior OSA 
dx) 
Conclusions: 
For the diabetic population 
§ For mild OSA (AHI 5-14) the most sensitive screening test 
was the STOP-Bang (sensitivity 87.2%)  
§ For moderate OSA (AHI 15—29) the most sensitive 
screening test was the Berlin  
§ Both Berlin and STOP-Bang were most sensitive for severe 
OSA (AHI >30)  
§ Most specific test was neck circumference with specificity of 
70.4%.  
Practice Implications/ Recommendations: 
§ Relying on neck circumference avoids the subjective 
questions 
§ A negative neck circumference and ESAP screening does not 
rule out OSA due to the low sensitivity 
§ Study reinforces the importance of screening OSA in patients 
with type 2 diabetes  
Study aimed to 
assess OSA risk 
using the Berlin 
questionnaire and 
Epworth 
Sleepiness Scale. 
Additionally, the 
study evaluates 
multiple 
morbidities to 
determine the 
epidemiological 
IV/Primary • Cross-sectional 
screening study of 
490 elderly adults 
(65+) utilizing 
home care services 
in Greece.  
§ Data collection 
between January 
and June 2010 
Conclusions: 
• High pre-test likelihood noted in individuals with history of 
stroke, diabetes, cardiovascular disease, and mental health 
disorders compared to others with no history of chronic 
disease.  
• Multiple co-morbidities (2+) showed statistically significance 
with high OSA likelihood.  
• Both the Berlin and ESS had good internal consistency 
(Cronbach’s alpha coefficient 0.69 (Berlin) and 0.77 (ESS).  
• One third of the studied population was considered high risk.  
Practice Implications/ Recommendations: 
 
 
link for the 
elderly 
population in the 
primary care 
(Kleisiaris et al., 
2016)  
• OSA in the older population often occurs along with multiple 
common chronic diseases 
• Recommends systematic screening in the primary care.  
Study to assess 
the rate of prior 
screening among 
patients prior to 
being 
hospitalized for 
persistent atrial 
fibrillation (AF) 
and willingness 
of patients to 
have further 
testing among 
those identified 
as moderate or 
high risk (Khan 
et al., 2019). 
IV/Primary • Total of 254 
persistent AF 
patients were 
surveyed regarding 
prior OSA 
screening.  
• STOP-Bang 
utilized to identify 
of patients not 
screened were 
moderate or high 
risk.  
• Prior 
cardioversions and 
willingness for 
further testing was 
also recorded in 
the study 
Conclusions: 
• 66% of AF patients were never screened for OSA.  
• Of the population that was not screened 75% were deemed 
high risk based on the STOP-Bang.  
• Individuals with prior hospitalizations or cardioversions were 
more likely to be screened for OSA.  
• Among the high-risk group 79% were interested in obtaining 
a sleep study.   
Practice Implications/ Recommendations: 
• Based on the population surveyed the majority of AF patients 
are not screened for OSA.  
• Study recommends OSA screening for AF patients be a focus 
for the primary care.  
 
Quality 
improvement 
study aimed at 
increasing the 
OSA diagnosis 
among patients 
with 
hypertension in a 
primary care 
setting (Bakhai, 
Nigam, Saeed, 
Primary/IV • Screened HTN 
patients in the 
primary care from 
July 2015-
December 2015 
using the STOP-
Bang 
questionnaire. 
• 1000 convenient 
OSA 
questionnaires 
completed at the 
Conclusions: 
• Retrospective review of patients seen at the clinic 
demonstrated that only 1% of patients with hypertension were 
screened and diagnosed with OSA. 
• Goal to increase OSA dx from baseline to 5% among HTN 
patients. (Goal not met due to multiple barriers)  
• Physician barriers to acceptance included: 1.) lack of EMR 
chart alerts 2.) lack of extra time needed to complete 
screening questionnaire.  
• Patient barriers to obtaining follow up sleep studies: 1.) fear 
of sleep study procedure 2.) fear of diagnosis and treatment 
3.) cost -due to high co-pay or lack of insurance 4.) lack of 
 
 
Krishnan, & 
Reynolds, 2017). 
internal medicine 
clinic among HTN 
patients.  
• 318/1000 patients 
screened high risk 
using the STOP-
Bang 
• Of the 255 patients 
with OSA (score 
between 3-5) 50% 
agreed to a sleep 
study referral.  
transportation to sleep study 5.) lack of knowledge regarding 
OSA  
Practice Implications/ Recommendations: 
• Integrate screening tool into the EMR 
• Provide OSA brochures for patients.  
A review of 
literature to 
determine if 
appropriate 
assessment of 
OSA at the PCP 
is being 
conducted 
(Aurora & Quan, 
2016). 
II/Secondary A total of 364 articles 
were reviewed that 
addressed sleep apnea, 
screening, and common 
comorbidities. 
Conclusion/Practice Implications/  
Recommendations: 
• After a review of cost-benefit of universal vs high risk patient 
population it was determined that screening should be limited 
to high risk groups.  
• Sleepiness scales are not recommended for identification of 
OSA as they are not as specific.  
• High risk groups include: “obesity (BMI ≥ 30 kg/m2), 
congestive heart failure, atrial fibrillation, treatment resistant 
hypertension (blood pressure above goal despite adherence to 
antihypertensive regimen of 3 medications, or hypertension 
controlled by at least 4 medications), impaired glucose 
tolerance or type 2 diabetes, nocturnal dysrhythmias, stroke, 
pulmonary hypertension, preoperative for bariatric surgery, 
coronary artery disease” (Aurora & Quan, 2016). 
 
Determine the 
value of STOP-
Bang OSA 
screening among 
hypertensive 
patients in the 
primary care 
setting 
IV/Primary A convenient sample of 32 
adult patients with 
hypertension taken over a 
three-month period. Two 
of the patients were then 
excluded due to already 
having an OSA dx.  
Results/Conclusions: 
• Small sample size (N=30) 
• 40% (n=12) screened high risk.  
• Only three patients that screened high risk obtained a sleep 
study. 
• However, all three that obtained the sleep study were 
diagnosed with OSA.  
Practice Implications/  
 
 
(Showalter & 
OʼKeefe, 2019).  
Recommendations: 
• Despite the small sample size, the study recommends a 
written protocol at the primary care clinic for screening OSA 
patients among patients with hypertension based on the 
conclusions in the study and prior literature.  
• Recommends providing alerts in the EMR for patients that 
quality for screening.  
 
Quality 
improvement 
study of 
implementing a 
protocol for OSA 
screening in the 
primary care 
setting using the 
STOP-Bang 
questionnaire 
(Ononye, 
Nguyen, & 
Brewer, 2019).  
III/Primary Convenient sample of 187 
patients participated in the 
study. Female patients 99 
(53%) male patients 88 
(47%).  
Conclusions: 
• Randomized chart audit (60 charts) noted that only 3% (n=2) 
of patients were routinely screened for OSA during visits pre-
protocol. 
• Randomized chart audit (60 charts) post-protocol 
implementation had an increase to 43% (n=26)  
• Referral rates increased after implementing the protocol pre-
protocol (0%) compared to post-protocol 39% (n=24).  
• Primary care physicians do not routinely screen for OSA. 
Potential barriers could be: uncertainty with identification 
diagnosis, best sleep monitors for OSA diagnosis, and how to 
manage patients once diagnosed.   
Practice Implications/  
Recommendations 
• Recommends utilizing a protocol in the primary care setting 
to improve detection and referral of patients at high risk for 
OSA.  
• States that the STOP-Bang has good utility in the primary 
care.  
Review the 
current screening 
an assessment of 
OSA in primary 
care as well as 
the validity of 
OSA 
questionnaires in 
the primary care 
II/Secondary • A review of 
articles published 
between 1991 and 
2014. A total of 17 
articles met the 
inclusion and 
exclusion criteria. 
Non-experimental 
(N=14) and 
Conclusions: 
• Consensus that there needs to be a screening tool for OSA in 
primary care.  
• Data limited on reliability of STOP-bang in the primary care.  
• Berlin questionnaire has psychometric properties for the 
primary care.  
• Epworth sleepiness scale has inconsistent sensitivity/ 
specificity for OSA.  
Practice Implications/  
 
 
setting (Miller & 
Berger, 2016).  
 
experimental 
(N=3) 
• Review was 
limited to the 
STOP, STOP-
Bang, Epworth 
sleepiness scale, 
and Berlin 
questionnaire. 
Recommendations 
• Supports the need for a standardized screening tool.  
• Suggests that the Berlin questionnaire may prove more 
beneficial in the primary care, but more studies are needed. 
The reliability of 
STOP-Bang 
questionnaire 
(Portuguese 
version) for the 
screening of 
OSA within the 
primary care in 
Portugal 
(Rebelo-
Marques,Vicente, 
Valentim, & 
Agostinho, 
2018).  
IV/Primary A convenient sample over 
8 months of two hundred 
fifty-nine patients (aged 
18 and older) that 
completed the STOP-Bang 
at a single primary care 
Conclusions: 
• Suggests that the STOP-Bang is a beneficial tool in other 
populations outside of the U.S given the high sensitivity. 
Practice Implications/  
Recommendations 
• Other tests should be used to confirm due to the low 
specificity. 
The value of 
using oximetry 
alone or in 
combination with 
the Phillips 
questionnaire in 
predicting OSA 
within the 
primary care 
(Fabius, 
Benistant, 
Pleijhuis, Van, & 
Eijsvogel, 2019).  
IV/Primary A total of 140 subjects 
with suspected OSA were 
include in the study from 
54 primary care practices. 
Conclusions: 
• OSA was diagnosed in 71% of the subjects. The oxygen 
desaturation index (ODI) (greater or equal to 5) had a 
sensitivity of 99% and specificity of 50%. When combined 
with the questionnaire sensitivity was 100% with specificity 
of 35%. 
Practice Implications/  
Recommendations 
• Supports that the oximetry alone or in combination is helpful 
to exclude OSA diagnosis due to high sensitivity. 
 
 
 
Identify the 
benefit of sleep 
apnea screening 
questionnaires 
(STOP-Bang, 
OSA-50, Berlin) 
alone and in 
combination with 
the Epworth 
 sleepiness scale 
(ESS) within the 
primary care 
setting 
(Senaratna, 
2019).  
IV/Primary • Performed within 
the Tasmanian 
Longitudinal 
Health Study 
(TAHS), 6th 
Decade Follow‐up 
• Random sample of 
772 participants 
were invited to 
participate in the 
study.  
• 424 patients 
participated in the 
study by 
completing 
questionnaires and 
home-based sleep 
studies.  
Conclusions: 
• Sensitivity/specificity of STOP-Bang alone (81% and 36% 
respectively) Sensitivity/specificity of STOP-Bang with ESS 
(50% and 92%) 
Practice Implications/  
Recommendations 
• The screening tools together with an ESS >8 are beneficial in 
ruling in but not ruling out clinically significant OSA.  
• The Stop-Bang/ESS may be a useful tool in the primary care 
for referrals. 
Determine the 
ability of the 
SACS tool to 
accurately detect 
OSA in the 
primary care 
setting (Grover, 
Mookadam, 
Chang, & Parish, 
2016). 
IV/Primary • 191 patients were 
included in the 
study. After 
completing the 
SACS participants 
completed an 
overnight 
oximetry, sleep 
medicine 
consultation and 
polysomnography.	
Conclusions: 
• With OSA defined as AHI≥ 10 a SACS score greater than 15 
was 40% sensitive and 90% specific for OSA 
Practice Implications/  
Recommendations 
• Due to the findings, the study suggest that the SACS 
screening tool is helpful in determining individuals at risk for 
OSA in the primary care setting.  
• Recommends further studies to determine best practices to 
facilitate use.  
• Suggests that clinical alerts and clinical decision support tools 
could prove beneficial in facilitating use and should be 
explored.  
Providing STOP-
Bang OSA 
questionnaire 
training to 
primary care 
IV/Primary • Education for 
STOP-Bang 
provided to 15 
primary care 
Conclusions: 
• Large increase in sleep study referrals for all primary care 
providers post implementation of the STOP-Bang.   
Practice Implication/ Recommendations 
 
 
providers to 
improve sleep 
study referrals 
(Addogoh, 
2018).  
providers at six 
different locations.  
• STOP-Bang 
questionnaire 
utilized for three 
months on patients 
over the age of 18 
being seen during 
wellness exams.  
• Recommends from the study include integrating the STOP-
Bang into the EMR and establishing a screening protocol.  
Integrating an 
Epworth 
Sleepiness Scale 
clinical advisor 
into the EMR to 
improve OSA 
screening 
(Johnson, 2019).  
III/Primary • Patients were 
selected by 
reviewing the 
EMR and 
including every 
fifth patient during 
the designated time 
frame. A total of 
50 patients 
selected from each 
6-week period to 
equal 150. The 
sample consisted 
of 150 men and 
women ages 18-92 
at an internal 
medicine office 
with two 
providers. 
• Chart reviews 
conducted for pre 
ESS for 6 weeks, 6 
weeks ESS 
learning phase, and 
6 weeks post 
implementation.  
Conclusions: 
• Imbedding the ESS in the EMR for screening of all internal 
medicine patients resulted in a 20% detection in high risk 
OSA patients.  
Practice Implication/ Recommendations 
• Integrating the ESS into the EMR can help to identify 
patients at risk that remain undiagnosed.  
• Recommends not only placing the ESS in the EMR but also 
including hard stops that require providers to screen every 
patient.  
 
 
Identifying the 
knowledge and 
attitudes of 
primary care 
providers in 
Malaysia with 
regards to 
obstructive sleep 
apnea utilizing 
the OSAKA 
questionnaire 
(Devaraj, 2020) 
VI/Primary • A convenient 
sample of 207 
primary care 
physicians, 
employed at a 
clinic in Kuala 
Lumpur Malaysia, 
were surveyed 
utilizing the 
OSAKA 
questionnaire.  
• Cross sectional 
study was 
completed over a 
3-month period 
during 2017.  
• Knowledge 
domain of the 
questionnaire asks 
18 questions.  
• Attitude domain 
asks 5 Likert scale 
questions.  
 
Conclusions: 
• Mean score for knowledge was 11.6 The OSAKA has a total 
maximum score of 18 for the knowledge domain. (mean score 
=65%) 
• More than 55% scored above the mean knowledge score.  
• The mean score for the attitude domain was 15.9. The 
OSAKA has a total maximum score of 24 for the attitude 
domain.  
• There was no single item that was answered correctly or 
incorrectly by all participants.  
• Findings from the study were consistent with previous studies 
done in other countries as it demonstrated similar knowledge 
and attitude scores.  
• Most of the primary care physicians that were screened do not 
utilize OSA screening tools.  
Practice Implication/ Recommendations 
• Recommends additional education on OSA for the primary 
care providers to improve overall knowledge and 
management of the condition.  
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